ANTX

AN2 Therapeutics, Inc. - Common Stock (ANTX)

About AN2 Therapeutics, Inc. - Common Stock (ANTX)

AN2 Therapeutics, Inc. operates as a global health biopharmaceutical company. The firm focuses on modern biomedical and drug development to provide transformational medicines for patients suffering from infectious diseases. The company was founded by Eric Easom, George Harrison Talbot, Joseph S. Zakrzewski and Michael R.K. Alley in 2017 and is headquartered in Menlo Park, CA.

Details

Daily high

$5.25

Daily low

$4.92

Price at open

$5.06

52 Week High

$7.19

52 Week Low

$1.00

Market cap

190.6M

Dividend yield

Volume

305,221

Avg. volume

227,796

P/E ratio

-4.71

AN2 Therapeutics, Inc. - Common Stock News